Literature DB >> 21354941

Optimising magnetic resonance image quality of the ear in healthy dogs.

Davina Wolf1, Matthias Lüpke, Patrick Wefstaedt, Thilo Klopmann, Ingo Nolte, Hermann Seifert.   

Abstract

The aim of this study was to develop an examination protocol for magnetic resonance imaging, in order to display diagnostically important information of the canine middle and inner ear. To ensure that this protocol could also be used as a basis for determining pathological changes, the anatomical structures of the ear were presented in detail. To minimise stress through anaesthesia in live animals, preliminary examinations were carried out on four dog cadavers. During these initial examinations, three-dimensional (3D) sequences proved to be superior to two-dimensional ones. Therefore, only 3D sequences were applied for the main examinations performed on six clinically healthy Beagles. The anonymised MR images were rated by three experienced reviewers using a five-point scale. The most valuable sequence was a T2-weighted CISS sequence (TR = 16.7 ms, TE = 8.08 ms). This sequence proved to be most suitable for illustrating the inner ear structures and enabled good tissue contrasts. The sequence ranked second best was also a T2-weighted DESS sequence (TR = 19 ms, TE = 6 ms), allowing the imaging of the tympanic cavity and enabling 3D reconstruction due to its isotropic voxels. Due to low contrast and strong noise, the other sequences (TSE, FISP, MP RAGE) were not suitable for anatomical illustration of the middle and inner ear.

Entities:  

Mesh:

Year:  2011        PMID: 21354941     DOI: 10.1556/AVet.59.2011.1.5

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  1 in total

1.  Functional magnetic resonance imaging of the ascending stages of the auditory system in dogs.

Authors:  Jan-Peter Bach; Matthias Lüpke; Peter Dziallas; Patrick Wefstaedt; Stefan Uppenkamp; Hermann Seifert; Ingo Nolte
Journal:  BMC Vet Res       Date:  2013-10-16       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.